{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:13:53Z","timestamp":1778174033040,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020908","name":"Pfizer France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.acvd.2025.10.333","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:20:13Z","timestamp":1767745213000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associated diseases and diuretic dosage to predict mortality in transthyretin amyloid cardiomyopathy"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-1235","authenticated-orcid":false,"given":"Vincent","family":"Algalarrondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-6582","authenticated-orcid":false,"given":"Olivier","family":"Lairez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Narbeburu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0320-4140","authenticated-orcid":false,"given":"Jerome","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francoise","family":"Pelcot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Farrugia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Durand-Zaleski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herve","family":"Lilliu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5517-6767","authenticated-orcid":false,"given":"Mathilde","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8013-2399","authenticated-orcid":false,"given":"Stephane","family":"Fievez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremie","family":"Rudant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agathe","family":"Coste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Noirot Cosson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5998-8285","authenticated-orcid":false,"given":"Pierre Alexandre","family":"Squara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Canali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4040-4038","authenticated-orcid":false,"given":"Bertrand","family":"de Neuville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel S.","family":"Slama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1782-1118","authenticated-orcid":false,"given":"Philippe","family":"Charron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2025.10.333_bib0130","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/1471-2458-12-974","article-title":"Incidence and survival in non-hereditary amyloidosis in Sweden","volume":"12","author":"Hemminki","year":"2012","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.acvd.2025.10.333_bib0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13023-023-02933-w","article-title":"Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases","volume":"18","author":"Damy","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"24","key":"10.1016\/j.acvd.2025.10.333_bib0140","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2025.10.333_bib0145","series-title":"Donn\u00e9es relatives \u00e0 l\u2019ensemble des b\u00e9n\u00e9ficiaires du dispositif des ALD une ann\u00e9e donn\u00e9e","year":"2019"},{"issue":"23","key":"10.1016\/j.acvd.2025.10.333_bib0150","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2025.10.333_bib0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ahj.2019.06.008","article-title":"Amyloid cardiomyopathy in a large integrated health care system","volume":"216","author":"Czobor","year":"2019","journal-title":"Am Heart J"},{"issue":"21","key":"10.1016\/j.acvd.2025.10.333_bib0160","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","article-title":"Aortic stenosis and cardiac amyloidosis: JACC review topic of the week","volume":"74","author":"Ternacle","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"27","key":"10.1016\/j.acvd.2025.10.333_bib0165","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1093\/eurheartj\/ehac259","article-title":"Characteristics and natural history of early-stage cardiac transthyretin amyloidosis","volume":"43","author":"Law","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.acvd.2025.10.333_bib0170","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/ehf2.12884","article-title":"Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan","volume":"7","author":"Yamada","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.acvd.2025.10.333_bib0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00392-019-01490-2","article-title":"When and how do patients with cardiac amyloidosis die?","volume":"109","author":"Escher","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.acvd.2025.10.333_bib0180","unstructured":"International Classification of diseases https:\/\/www.who.int\/standards\/classifications\/classification-of-diseases."},{"key":"10.1016\/j.acvd.2025.10.333_bib0185","unstructured":"WHO. WHO Collaborating Centre for Drug Statistics Methodology, \u201cStructure and principles\u201d."},{"key":"10.1016\/j.acvd.2025.10.333_bib0190","unstructured":"CCAM. Classification Commune des Actes M\u00e9dicaux."},{"issue":"3","key":"10.1016\/j.acvd.2025.10.333_bib0195","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaccao.2020.06.007","article-title":"Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis","volume":"2","author":"Cheng","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.acvd.2025.10.333_bib0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13506129.2022.2098011","article-title":"Natural course and determinants of short-term kidney function decline in hereditary transthyretin amyloidosis: a French observational study","volume":"30","author":"Dang","year":"2023","journal-title":"Amyloid"},{"issue":"30","key":"10.1016\/j.acvd.2025.10.333_bib0205","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.acvd.2025.10.333_bib0210","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jacc.2023.12.036","article-title":"Stratifying disease progression in patients with cardiac ATTR amyloidosis","volume":"83","author":"Ioannou","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"31","key":"10.1016\/j.acvd.2025.10.333_bib0215","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/eurheartj\/ehaf218","article-title":"Cardiologist follow-up and improved outcomes of heart failure: a French nationwide cohort","volume":"46","author":"Baudry","year":"2025","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.acvd.2025.10.333_bib0220","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neurol.2011.05.010","article-title":"[Carpal tunnel syndrome surgery in France in 2008: patients\u2019 characteristics and management]","volume":"167","author":"Tuppin","year":"2011","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"10.1016\/j.acvd.2025.10.333_bib0225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies","volume":"22","author":"Milandri","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2025.10.333_bib0230","series-title":"L\u2019\u00e9tat de sant\u00e9 de la population en France. Rapport 2017","year":"2017"},{"issue":"2","key":"10.1016\/j.acvd.2025.10.333_bib0235","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.acvd.2024.08.006","article-title":"Clinical outcomes for 2788 patients with transthyretin amyloidosis: Tafamidis meglumine early access program in France","volume":"118","author":"Lairez","year":"2025","journal-title":"Arch Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.acvd.2025.10.333_bib0240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.acvd.2024.10.323","article-title":"Management of conduction disease and arrhythmias in patients with cardiac amyloidosis: a position paper from the Working Group of Cardiac Pacing and Electrophysiology of the French Society of Cardiology","volume":"118","author":"Lellouche","year":"2025","journal-title":"Arch Cardiovasc Dis"},{"issue":"8\u20139","key":"10.1016\/j.acvd.2025.10.333_bib0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.acvd.2024.04.007","article-title":"Cardiac amyloidosis prevalence and 1-year outcome in patients with aortic stenosis undergoing transaortic valve implantation: findings from the CAMPOS-TAVI study","volume":"117","author":"Costa","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"issue":"67","key":"10.1016\/j.acvd.2025.10.333_bib0250","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.acvd.2025.03.121","article-title":"Underestimated vascular dysfunction is a critical feature of the impaired cardiovascular profile in patients with transthyretin amyloidosis","volume":"118","author":"Monfort","year":"2025","journal-title":"Arch Cardiovasc Dis"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213626000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213626000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:03:54Z","timestamp":1778173434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213626000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1875213626000021"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2025.10.333","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associated diseases and diuretic dosage to predict mortality in transthyretin amyloid cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2025.10.333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}